Pretreatment of organophosphate poisoning: Potential interests of huperzine A;Pretraitement de l'intoxication organophosphoree: Interets potentiels de l'huperzine A

Annales Pharmaceutiques Francaises

Volumn 58, Issue 1, 2000, Pages 13-17

  Lallement, G ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Acethylcholinesterase; Huperzine A; Organophosphates

Indexed keywords

CHOLINESTERASE; HUPERZINE A; ORGANOPHOSPHATE; PYRIDOSTIGMINE; ANTIDOTE; CHOLINESTERASE INHIBITOR; ORGANOPHOSPHORUS COMPOUND; SESQUITERPENE;

CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; HUMAN; INTOXICATION; NEUROPROTECTION; PERIPHERAL NERVOUS SYSTEM; PREMEDICATION; SHORT SURVEY; ARTICLE; DRUG ANTAGONISM;

ANTIDOTES; CHOLINESTERASE INHIBITORS; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; POISONING; SESQUITERPENES;

EID: 0033631802     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Gordon JJ, Leadbeater L, Maidment MP. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicology and Applied Pharmacology 1978, 43: 207-16.
2. Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J of Pharmacology 1979, 31: 295-9.
3. Pilotaz F, Masson P. L'huperzine A : un inhibiteur de l'actéylcholinestérase à fort potentiel pharmacologique. Ann Pharm Fr 1999, 57: 363-73.
4. Lallement G, Veyret J, Masqueliez C, Aubriot S, Burckhart MF, Baubichon D. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol 1997, 11: 387-94.
5. Lallement G, Carpentier P, Collet A, Pernot-Marino I, Baubichon D, Blanchet G. Effect of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res 1991, 563: 234-40.
6. Ved HS, Koenig ML, Dave JR, Doctor BP. Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. Neuro Report 1997, 8: 963-8
7. Grunwald J, Raveh L, Doctor BP, Ashani Y. Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 1994, 54: 991-7.
8. Ashani Y, Grunwald J, Alkalai D, Cohen G, Raveh L. Studies with huperzine A, a new candidate in the research of prophylaxis against nerve agent Proc Med Defence Biesel Rev 1996, 105-10.
9. Lallement G, Foquin A, Baubichon D, Carpentier P, Does blood-brain barrier permeability for proteins be aflected by various pretreatments of nerve agent intoxication? Drug Chem Toxicol, soumis
10. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. Pharmacol Exp Ther 1991, 259: 633-8.
11. Cohen SD. Carboxylesterase inhibition and potentiation of soman toxicity. Arch Toxicol 1981, 49: 105-6.
12. Filliat P, Foquin A, Lallement G. Effects of chronic administration of huperzine A on spatial memory in the guinea-pig. J Pharmacol Exp Ther, soumis.
13. Camp P Fl-Achab R, Gorbig DM, Morral J, Munoz-Torrero D Badia A Eladi-Banos J, Vivas NM, Barril X, Orozco M, Luque FJ Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. J Med Chem 1999, 42: 3227-42.
14. Badia A, Banos JE, Camps P, Contreras J, Gorbig DM, Munoz-Torrero D, Simon M, Vivas NM. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. Bioorg Med Chem 1998, 6: 427-40.
15. Carlier PR, Du DM, Han Y, Liu J, Pang YP. Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors. Bioorg Med Chem 1999, 9: 2335-8.